Peter Lanciano

Peter Lanciano, president of Altus Biologics Inc.

TRENDING

Securitization

New Jersey higher education agency to float about $226.5 million

Broken down by product type, the agency's NJCLASS Standard Fixed product should account for a large majority of the loans, 75.4%. NJCLASS Consolidation will account for the next-largest group, 14.1%.

By Donna M. Mitchell

April 24
Securitization

Duke Energy Progress prepares to issue $177.3 million in storm recovery bonds

The notes will price against Treasurys, with spreads expected to fall between 85 and 90 basis points over the benchmark.

By Donna M. Mitchell

April 24
Securitization

FTC issues worker non-compete ban as chamber lawsuit looms

The high-stakes legal showdown comes three years after President Joseph Biden signed an executive order encouraging the FTC to limit non-compete agreements, which affect roughly one in five Americans.

By Leah Nylen and Emily Birnbaum

April 24